Tuesday, October 20, 2015

How the Immune System Could "Cure" Cancer

Podcast: Top Researcher Says Antibodies Key to Unleashing Cancer-Killing T-Cells

By Marc Dresner, IBC Life Sciences

The “cure” for cancer may already reside in the human body. It just needs to be activated.

Dr. Louis M. Weiner
Indeed, Dr. Louis Weiner, Director of the Lombardi Comprehensive Cancer Center and Georgetown University Medical Center’s Department of Oncology Chair, says the immune system could potentially dispense with cancer much in the way it fights an infectious disease.

Sound a little crazy? That’s fine by Weiner.

Thirty years ago, his colleagues said he was nuts to dedicate himself to anything as “radical and unpromising” as using antibodies to treat cancer; today they constitute the backbone therapies for many cancers.

Dr. Weiner and other, likeminded pioneers are now taking the field in an extraordinary new direction in pursuit of a stunningly elegant solution: using antibodies to neutralize cancer’s ability to protect itself from being destroyed by T-cells.

We are really on the verge of breaking down the defenses of cancer that have been erected to avoid immune destruction.”

“We are really on the verge of breaking down the defenses of cancer that have been erected to avoid immune destruction,” said Dr. Weiner.

In this podcast interview for Inside Antibody Engineering, Dr. Louis Weiner shares his thoughts on the state of unconjugated antibodies in cancer treatment, what the future holds for antibody drug conjugates for cancer treatment and how the immune system may be deployed to fight cancer.

Listen to the podcast or download a transcript here!

Editor’s note: Dr. Louis Weiner will speak on “Targeting Cancer’s Fragile Strength with Immunotherapy” at the Antibody Engineering and Therapeutics Conference taking place December 7-10 in San Diego.

Or for more information visit: www.ibclifesciences.com/antibodyeng

(Ps. SAVE $100 when you register with code D15172BLOG!)

Marc Dresner is sr. editor and special communication project lead with IBC Life Sciences. He is the former executive editor of Pharma Market Research Report, a publication for market research professionals specializing in pharmaceuticals and life sciences. He may be reached at mdresner@iirusa.com. Follow him @mdrezz.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment